Summit Therapeutics (SMMT) Receivables (2014 - 2022)
Summit Therapeutics (SMMT) posted Receivables of $349,000 for Q4 2022, down 82.9% from $2.04 million a year earlier but up 149.3% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Receivables (2014 - 2022) Analysis & Trends
Since Q4 2018, Summit Therapeutics has reported Receivables for 15 quarters.
- Annual Receivables shows a five-year compound annual growth rate of -27.2% (FY2017 to FY2022).
- In prior years, Summit Therapeutics' Receivables was $2.04 million in FY2021 (+515.7%), $331,000 in FY2020 (-80.8%), $1.73 million in FY2019 and $22.74 million in FY2018.
- Quarterly Receivables has run from a low of $140,000 in Q3 2022 to a high of $22.67 million in Q4 2018 over five years.
- On a year-over-year basis, Receivables increased in three of the last seven quarters, with growth averaging 63.7%.
- The strongest year-over-year quarter for Receivables in the past five years was Q4 2021, with growth of 515.7%; the weakest was Q4 2020, with a decline of 97.2%.
- According to Business Quant data, Receivables for the three prior quarters was $140,000 (Q3 2022), $1.35 million (Q2 2022) and $1.43 million (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Summit Therapeutics | 14.26 Bn | 11.63 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 349,000.00 |
| Sep 30, 2022 | 140,000.00 |
| Jun 30, 2022 | 1.35 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 2.04 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Jun 30, 2021 | 1.05 Mn |
| Mar 31, 2021 | 447,000.00 |
| Dec 31, 2020 | 331,000.00 |
| Sep 30, 2020 | 4.08 Mn |
| Mar 31, 2020 | 12.10 Mn |
| Dec 31, 2019 | 11.83 Mn |
| Oct 31, 2019 | 11.55 Mn |
| Jul 31, 2019 | 12.99 Mn |
| Jan 31, 2019 | 22.67 Mn |
| Dec 23, 2017 | 1.51 Mn |
| Jan 31, 2017 | 1.71 Mn |
| Apr 30, 2015 | 2.94 Mn |
| Jan 31, 2015 | 3.97 Mn |
| Jan 31, 2014 | 711,080.32 |
API Access
Summit Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();